| Publication Date | Title | Author(s) |
| May-2021 | Citizen brief: Accessing precision therapies for children and youth in Canada | Gauvreau, CI; Subasri, M; Wilson, MG; Denburg, AE |
| Nov-2016 | Citizen Brief: Addressing Health System Sustainability in Ontario | Waddell, K; Wilson, MG; Moat, KA; Lavis, JN |
| Feb-2016 | Citizen Brief: Building a Primary-Care 'Home' for Every Ontarian | Wilson, MG; Lavis, JN; Moat, KA |
| Feb-2024 | Citizen brief: Creating a system to support the adaptation and uptake of health-system innovations in Canada | Gauvin, François-Pierre; Wilson, MG |
| Jul-2024 | Citizen brief: Developing a Type 1 diabetes screening program in Canada | Wilson, MG; Scallan, Eilish; Hayeems, R; Bain, T; Velez, CM |
| Oct-2016 | Citizen Brief: Enhancing Access to Patient-centred Primary Care in Ontario | Wilson, MG; Waddell, K; Lavis, JN |
| May-2017 | Citizen Brief: Enhancing Equitable Access to Assistive Technologies in Canada | Mattison, CA; Waddell, K; Wang, RH; Wilson, MG |
| Apr-2019 | Citizen brief: Enhancing the delivery of comprehensive care for people living with HIV in Canada | Wilson, MG; Mattison, CA; Gao, C; Kendall, CE; Lavis, JN |
| Jan-2021 | Citizen brief: Identifying and harnessing the potential of technology in long-term care settings in Canada | Gauvin, François-Pierre; DeMaio, P; Alam, S; Drakos, A; Lavis, JN; Wilson, MG |
| Feb-2014 | Citizen Brief: Improving Care and Support for People with Multiple Chronic Health Conditions in Ontario | Gauvin, François-Pierre; Wilson, MG; Lavis, JN; Abelson, J |
| Nov-2014 | Citizen Brief: Improving Care and Support for Unpaid Caregivers in Ontario | Wilson, MG; Gauvin, François-Pierre; Ploeg, J |
| Mar-2016 | Citizen Brief: Integrating Data Across Sectors for Public Service Improvement in Ontario | Moat, KA; Wicks, M; Wilson, MG |
| Aug-2014 | Citizen Brief: Meeting the Future Home and Community Care Needs of Older Adults in Ontario | Wilson, MG; Gauvin, François-Pierre; Lavis, JN |
| Feb-2019 | Citizen brief: Preventing and managing infectious disease among people who inject drugs in Ontario | Waddell, K; Sharma, K; Wilson, MG |
| Aug-2016 | Citizen Brief: Strengthening Care for Frail Older Adults in Canada | Wilson, MG; Waddell, K; Guta, Adrian |
| Apr-2016 | Citizen Brief: Strengthening Care for People with Chronic Diseases in Ontario | Wilson, MG; Lavis, JN; Moat, KA; Guta, A |
| Sep-2017 | Citizen Brief: Taking a Step Towards Achieving Worry-free Surgery in Ontario | Gauvin, François-Pierre; Wilson, MG; Lavis, JN |
| Nov-2022 | Citizen brief: Using remote-monitoring technologies to enable people to stay in their homes in Canada | Gauvin, François-Pierre; Wilson, MG; Lavis, JN |
| Jan-2021 | COVID-19 living evidence profile #1 (version 1.2): What is known about anticipated COVID-19 vaccine roll-out elements? | Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Bhuiya, AR; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Drakos, A; Sharma, K; Whitelaw, S; Lavis, JN |
| Feb-2021 | COVID-19 living evidence profile #1 (version 1.3): What is known about anticipated COVID-19 vaccine roll-out elements? | Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Bhuiya, AR; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Drakos, A; Sharma, K; Whitelaw, S; Lavis, JN |
| Feb-2021 | COVID-19 living evidence profile #1 (version 1.4): What is known about anticipated COVID-19 vaccine roll-out elements? | Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Bhuiya, AR; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Drakos, A; Sharma, K; Whitelaw, S; Lavis, JN |
| Mar-2021 | COVID-19 living evidence profile #1 (version 1.5): What is known about anticipated COVID-19 vaccine roll-out elements? | Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Bhuiya, AR; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Drakos, A; Sharma, K; Whitelaw, S; Lavis, JN |
| Apr-2021 | COVID-19 living evidence profile #1 (version 1.6): What is known about anticipated COVID-19 vaccine roll-out elements? | Bhuiya, AR; Bain, T; Wang, Q; Al-Khateeb, S; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Drakos, A; Rintjema, J; Sharma, K; Santesso, N; Lavis, JN; Wilson, MG |
| May-2021 | COVID-19 living evidence profile #1 (version 1.7): What is known about anticipated COVID-19 vaccine roll-out elements? | Bhuiya, AR; Bain, T; Wang, Q; Al-Khateeb, S; DeMaio, P; Ahmad, A; Drakos, A; Rintjema, J; Sharma, K; Matthews, M; Gauvin, François-Pierre; Lavis, JN; Wilson, MG |
| Mar-2021 | COVID-19 living evidence profile #2 (version 2.2): What is known about preventing and managing COVID-19, outbreaks of COVID-19, and about supporting renewal in long-term care homes? | Waddell, K; DeMaio, P; Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Alam, S; Sharma, K; Whitelaw, S; Gauvin, François-Pierre; Lavis, JN |
| Apr-2021 | COVID-19 living evidence profile #2 (version 2.3): What is known about preventing and managing COVID-19, outbreaks of COVID-19, and about supporting renewal in long-term care homes? | Waddell, K; DeMaio, P; Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Alam, S; Sharma, K; Whitelaw, S; Gauvin, François-Pierre; Lavis, JN |
| Jul-2021 | COVID-19 living evidence profile #2 (version 2.4): What is known about preventing and managing COVID-19, outbreaks of COVID-19, and about supporting renewal in long-term care homes? | Waddell, K; DeMaio, P; Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Alam, S; Sharma, K; Whitelaw, S; Gauvin, François-Pierre; Lavis, JN |
| Oct-2021 | COVID-19 living evidence profile #2 (version 2.5): What is known about supporting renewal in long-term care homes? | Waddell, K; Wilson, MG; Bain, T; Bhuiya, AR; Al-Khateeb, S; Lavis, JN |
| May-2021 | COVID-19 living evidence profile #3 (version 3.1): What is known about how schools (K-12) and postsecondary institutions (colleges and universities) adjust COVID-19 transmission-mitigation measures as infection rates change and vaccination rates increase? | Bain, T; Bhuiya, AR; Al-Khateeb, S; Wang, Q; Mansilla, C; Rintjema, J; DeMaio, P; Alam, S; Gauvin, François-Pierre; Santesso, N; Lavis, JN; Wilson, MG |
| Apr-2020 | COVID-19 rapid evidence profile # 2: What is known about the spread and management of COVID-19 in non-health workplaces? | Waddell, K; Gauvin, François-Pierre; Wilson, MG; Moat, KA; Mansilla, C; Lavis, JN |
| May-2020 | COVID-19 rapid evidence profile #10: What screening approaches can be used in non-healthcare settings (e.g., universities, stores and office settings) to identify people who may have COVID-19 and need to take appropriate action? | Wilson, MG; Waddell, K; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Lavis, JN |
| May-2020 | COVID-19 rapid evidence profile #11: What is the evidence related to playground equipment and risk of COVID-19 transmission? | Waddell, K; Wilson, MG; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Voorheis, P; Bhuiya, AR; Ahmad, A; Sharma, K; Lavis, JN |
| Jun-2020 | COVID-19 rapid evidence profile #12: What insights from the available evidence and jurisdictional scans can inform who should be tested for COVID-19 and how frequently, where, by whom and with what follow-up actions should they be tested? | Wilson, MG; Waddell, K; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Voorheis, P; Bhuiya, AR; Ahmad, A; Lavis, JN |
| Jun-2020 | COVID-19 rapid evidence profile #13: What pandemic-related mental health and addictions issues have emerged and what indicators and strategies can be used to monitor and address them, respectively? | Waddell, K; Wilson, MG; Bullock, HL; Evans, C; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Voorheis, P; Bhuiya, AR; Ahmad, A; Lavis, JN |
| Jun-2020 | COVID-19 rapid evidence profile #14: Where and with what impacts have shifts from in-person to virtual approaches occurred in the delivery of healthcare services in general and mental health and addictions services in particular? | Waddell, K; Bullock, HL; Evans, C; Wilson, MG; Gauvin, François-Pierre; Moat, KA; Mansilla, C; Wang, Q; Bhuiya, AR; Ahmad, A; Filbey, L; Lavis, JN |
| Jul-2020 | COVID-19 rapid evidence profile #15: What frameworks from available evidence and experiences in other countries can inform what needs to be done to plan for future waves of COVID-19? | Wilson, MG; Waddell, K; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Bhuiya, AR; Voorheis, P; Ahmad, A; Gao, C; Alam, S; Lavis, JN |
| Jul-2020 | COVID-19 rapid evidence profile #16: What provider-led virtual-care services can be used to replace in-person care in hospital-based ambulatory care settings? | Wilson, MG; Waddell, K; Wang, Q; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Ahmad, A; Alam, S; Bhuiya, AR; Lavis, JN |
| Aug-2020 | COVID-19 rapid evidence profile #17: What evidence could support modelling scenarios related to the reopening, operation and monitoring of schools? | Wilson, MG; Waddell, K; Moat, KA; Wang, Q; Ahmad, A; Alam, S; Bhuiya, AR; Sharma, K; Lavis, JN |
| Sep-2020 | COVID-19 rapid evidence profile #18: Which types of non-medical masks are effective in community settings for reducing the spread of COVID-19 for different populations and under different conditions? | Waddell, K; Wilson, MG; Gauvin, François-Pierre; Moat, KA; Wang, Q; Ahmad, A; Bhuiya, AR |
| Sep-2020 | COVID-19 rapid evidence profile #19: What is the risk of transmission of COVID-19 in hospital and long-term care settings, and the impacts of hospital-visitor policies? | Waddell, K; Wilson, MG; Moat, KA; Wang, Q; Gauvin, François-Pierre; Ahmad, A; Alam, S; Bhuiya, AR; Tchakerian, N; Lavis, JN |
| Apr-2020 | COVID-19 rapid evidence profile #1: What is known about approaches to and safety of conserving, reusing, and repurposing different kinds of masks? | Wilson, MG; Gauvin, François-Pierre; Waddell, K; Moat, KA; Lavis, JN |
| Oct-2020 | COVID-19 rapid evidence profile #20: What living, full or rapid reviews have been produced that provide evidence about economic and social responses to COVID-19? | Wilson, MG; Waddell, K; Moat, KA; Wang, Q; Lavis, JN |
| Oct-2020 | COVID-19 rapid evidence profile #21: What is the impact of the pandemic on substance use (particularly, alcohol and opioid use) in the population, and what policy decisions have been adopted that affect the availability and use of substances, as well as services for people who use substances? | Bullock, H; Waddell, K; Bhuiya, AR; Wilson, MG; Gauvin, François-Pierre; Moat, KA; Alam, S; Lavis, JN |
| Oct-2020 | COVID-19 rapid evidence profile #22: What is known about whether vaccine injury-compensation programs and program elements affect vaccine acceptance and uptake? | Bhuiya, AR; Waddell, K; Moat, KA; Wilson, MG; Gauvin, François-Pierre; Whitelaw, S; Alam, S; Sharma, K; Drakos, A; Lavis, JN |
| Nov-2020 | COVID-19 rapid evidence profile #23: What is known about anticipated COVID-19 vaccine-delivery program elements, and whether and how federated states are harmonizing these elements across constituent units of federations? | Bhuiya, AR; Wilson, MG; Moat, KA; Gauvin, François-Pierre; Wang, Q; Whitelaw, S; Alam, S; Sharma, K; Ahmad, A; Drakos, A; Dren, N; Bain, T; Lavis, JN |
| Jan-2021 | COVID-19 rapid evidence profile #25: What do we know from both research and jurisdictional scans about prioritizing vaccination of asymptomatic residents in a long-term care home with an outbreak? | Wang, Q; Wilson, MG; Alam, S; Ahmad, A; Bain, T; Bhuiya, AR; Drakos, A; Sharma, K; Whitelaw, S; Bain, T; Lavis, JN |
| Mar-2021 | COVID-19 rapid evidence profile #26: When and in what order can COVID-19-related public-health measures be lifted (or stringency be reduced) as vaccination rates and seasonal temperatures increase? | Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Bhuiya, AR; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Sharma, K; Whitelaw, S; Lavis, JN |
| Jan-2022 | COVID-19 rapid evidence profile #27: What measures and approaches can protect the most vulnerable in hospitals when outbreaks of Omicron in hospital are becoming more common? | Wilson, MG; Bhuiya, AR; Bain, T; Al-Khateeb, S; Mansilla, C; Mehta, V; Sood, T; Soueidan, S; Rintjema, J; Waddell, K; Wang, A; Wang, Q; Wang, X; Lavis, JN |
| Jan-2022 | COVID-19 rapid evidence profile #28: What is the filtration performance of KN95 masks compared to surgical and N95 masks, and how can their use be optimized in hospital settings? | Al-Khateeb, S; Bain, T; Bhuiya, AR; Mansilla, C; Mehta, V; Sood, T; Wang, Q; Soueidan, S; Rintjema, J; Wang, A; Lavis, JN; Wilson, MG |
| Apr-2020 | COVID-19 rapid evidence profile #3: What is the evidence about international and Canadian experiences with asymptomatic screening to identify COVID-19 cases and to prevent transmission? | Wilson, MG; Waddell, K; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Lavis, JN |
| Jan-2023 | COVID-19 rapid evidence profile #46: How were downstream health-promotion approaches that focus on individual behaviour change used during the public-health response to the COVID-19 pandemic? | Waddell, K; Velez, CM; DeMaio, P; Bain, T; Alam, S; Wilson, MG |
| Apr-2020 | COVID-19 rapid evidence profile #4: What are the most effective non-medical masks for preventing community transmission of COVID-19, and should they be required for all of society? | Wilson, MG; Gauvin, François-Pierre; Moat, KA; Waddell, K; Mansilla, C; Wang, Q; Lavis, JN |
| Apr-2020 | COVID-19 rapid evidence profile #5: What is known about the use of medical masks by essential non-medical workers to prevent community transmission of COVID-19? | Waddell, K; Gauvin, François-Pierre; Wilson, MG; Moat, KA; Mansilla, C; Wang, Q; Lavis, JN |
| Apr-2020 | COVID-19 rapid evidence profile #6: What is known about strategies for supporting the use of masks under shortage conditions to prevent COVID-19? | Waddell, K; Wilson, MG; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Lavis, JN |
| May-2020 | COVID-19 rapid evidence profile #7: What are the international lessons learned from re-opening non-COVID-19 activities in hospitals? | Waddell, K; Wilson, MG; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Lavis, JN |
| May-2020 | COVID-19 rapid evidence profile #8: How effective is temperature taking at borders or in general as a screening tool to identify people who may have COVID-19 and need to take appropriate action? | Wilson, MG; Waddell, K; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Lavis, JN |
| May-2020 | COVID-19 rapid evidence profile #9: What is the incremental benefit of using a history of sudden loss of taste (ageusia) and/or smell (anosmia) in symptom screening to identify people who may have COVID-19 and need to take appropriate action? | Waddell, K; Wilson, MG; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Lavis, JN |
| Sep-2019 | Dialogue summary: Addressing area-level disparities in prices of tobacco and vaping products in Ontario and Québec | Wilson, MG; Guindon, GE |
| Nov-2018 | Dialogue summary: Addressing overuse of health services in Canada | Wilson, MG; Lavis, JN |
| Jun-2015 | Dialogue Summary: Advancing the Development of National Childhood Cancer-care Strategies in Latin America | Denburg, A; Wilson, MG; Kutluk, T; Gupta, S |
| Mar-2016 | Dialogue Summary: Building a Primary-Care 'Home' for Every Ontarian | Wilson, MG; Guta, A; Lavis, JN |
| Mar-2024 | Dialogue summary: Creating an integrated innovation system to enable the adaptation and uptake of health-system innovations in Canada | Bhuiya, AR; Cura, J; Wilson, MG |
| Oct-2013 | Dialogue Summary: Designing Integrated Approaches to Support People with Multimorbidity in Ontario | Wilson, MG; Lavis, JN |
| Sep-2024 | Dialogue summary: Developing a Type 1 diabetes program in Canada | Wu, N; Hayeems, R; Wilson, MG |
| Mar-2014 | Dialogue Summary: Developing a ‘Rapid-response’ Program for Health System Decision-makers in Canada | Wilson, MG; Gauvin, François-Pierre; Lavis, JN |
| Jun-2011 | Dialogue Summary: Engaging Health System Decision-makers in Supporting Comprehensive Chronic Pain Management in Provincial and Territorial Healthcare Systems in Canada | Wilson, MG; Lavis, JN |
| Jun-2017 | Dialogue Summary: Enhancing Equitable Access to Assistive Technologies in Canada | Waddell, K; Wilson, MG; Mattison, CA |
| May-2019 | Dialogue summary: Enhancing the delivery of comprehensive care for people living with HIV in Canada | Waddell, K; Wilson, MG; Lavis, JN |
| Feb-2021 | Dialogue summary: Identifying and harnessing the potential of technology in long-term care settings in Canada | Wilson, MG; Gauvin, Francois-Pierre; Alam, S; Drakos, A |
| Feb-2020 | Dialogue summary: Implementing a policy vision for enhancing equitable access to assistive technologies in Canada | Jarvis, T; Wang, RH; Wilson, MG |
| Nov-2015 | Dialogue Summary: Improving Pain and Symptom Management in Cancer Care in Ontario | Moat, KA; Wilson, MG; Lavis, JN |
| Mar-2015 | Dialogue Summary: Optimizing Clinical Practice in Ontario Based on Data, Evidence and Guidelines | Wilson, MG; Lavis, JN |
| Mar-2018 | Dialogue Summary: Optimizing Patient and Family Transitions from Cancer Treatment to Primary- and Community-care Supports in Canada | Mattison, CA; Wilson, MG |
| Nov-2011 | Dialogue Summary: Organizing a Care System for Older Adults in Ontario | Wilson, MG; Lavis, JN |
| Feb-2019 | Dialogue summary: Preventing and managing infectious disease among people who inject drugs in Ontario | Waddell, K; Wilson, MG |
| Sep-2012 | Dialogue Summary: Promoting Healthy Weights Using Population-based Interventions in Canada | Wilson, MG; Lavis, JN; Guindon, GE |
| Sep-2012 | Dialogue Summary: Promouvoir un poids santé par des interventions populationnelles au Canada | Wilson, MG; Lavis, JN; Guindon, EG |
| Oct-2013 | Dialogue Summary: Soutenir des approches optimales de dépistage au Canada | Wilson, MG; Lavis, JN |
| Oct-2016 | Dialogue Summary: Strengthening Care for Frail Older Adults in Canada | Waddell, K; Wilson, MG |
| Apr-2016 | Dialogue summary: Strengthening care for people with chronic diseases in Ontario | Wilson, MG; Lavis, JN |
| Oct-2013 | Dialogue Summary: Supporting Optimal Screening Approaches in Canada | Wilson, MG; Lavis, JN |
| May-2021 | Dialogue summary: Supporting pregnant, lactating and parenting people who consume cannabis in Ontario | Gauvin, Francois-Pierre; Ion, A; Wilson, MG |
| Oct-2017 | Dialogue Summary: Taking a Step Towards Achieving Worry-free Surgery in Ontario | Gauvin, François-Pierre; Wilson, MG; Mattison, CA |
| Sep-2015 | Dialogue summary: Using financial incentives to achieve health-system goals in Ontario | Wilson, MG; Moat, KA; Lavis, JN |
| Dec-2022 | Dialogue summary: Using remote-monitoring and associated technologies to enable people to stay in their homes or existing level of care settings in Canada | Gauvin, Francois-Pierre; Wilson, MG |
| Feb-2024 | Document d’information à l’intention des citoyens : Créer un système pour soutenir l’adaptation et l’adoption des innovations du système de santé au Canada | Gauvin, François-Pierre; Wilson, MG |
| Aug-2024 | Document d’information à l’intention des citoyens : Élaborer un programme de dépistage du diabète de type 1 au Canada | Wilson, MG; Scallan, Eilish; Hayeems, R; Bain, T; Velez, CM |
| Nov-2022 | Document d’information à l’intention des citoyens : L’utilisation des technologies de télésurveillance pour permettre aux personnes de rester dans leur domicile au Canada | Gauvin, François-Pierre; Wilson, MG; Lavis, JN |
| Jan-2021 | Document d’information à l’intention des citoyens: identifier et exploiter le potentiel de la technologie dans les établissements de soins de longue durée au Canada | Gauvin, François-Pierre; DeMaio, P; Alam, S; Drakos, A; Lavis, JN; Wilson, MG |
| 12-Apr-2019 | Enhancing the Delivery of Comprehensive Care for People Living with HIV in Canada | Wilson, MG; Mattison, CA; Gao, C; Kendall, CE; Lavis, JN |
| Sep-2019 | Evidence brief: Addressing area-level disparities in prices of tobacco and vaping products in Ontario and Québec | Guindon, Emmanuel G.; Fatima, T; Buckley, G; Montreuil, A; Lavis, JN; Wilson, MG |
| Nov-2016 | Evidence Brief: Addressing Health-system Sustainability in Ontario | Moat, KA; Waddell, K; Wilson, MG; Lavis, JN |
| Nov-2015 | Evidence Brief: Addressing Overuse of Health Services in Canada | Ellen, ME; Wilson, MG; Grimshaw, JM; Lavis, JN |
| Jun-2015 | Evidence Brief: Advancing the development of national childhood cancer-care strategies in Latin America | Denburg, A; Wilson, MG; Gupta, S; Kutluk, T; Torode, J |
| Mar-2016 | Evidence Brief: Building a Primary-Care 'Home' for Every Ontarian | Wilson, MG; Reid, RJ; Lavis, JN; Moat, KA; Guta, A |
| Jun-2012 | Evidence Brief: Coordinating the Use of Genetic Tests and Related Services in British Columbia | Gauvin, François-Pierre; Wilson, MG |
| Mar-2024 | Evidence brief: Creating an integrated innovation system to enable the adaptation and uptake of health-system innovations in Canada | Wilson, MG; Bhuiya, AR; DeMaio, P; Gauvin, François-Pierre; Moat, KA; Cura, J; Lavis, JN |
| Jun-2017 | Evidence Brief: Enhancing Equitable Access to Assistive Technologies in Canada | Mattison, CA; Wilson, MG; Wang, RH; Waddell, K |
| May-2019 | Evidence brief: Enhancing the delivery of comprehensive care for people living with HIV in Canada | Wilson, MG; Mattison, CA; Gao, C; Scallan, Eilish; Kendall, CE; Lavis, JN |
| Oct-2022 | Evidence brief: Ensuring that the health-related decisions affecting Canadian military personnel, Veterans, and their families are informed by the best available evidence | Lavis, JN; Waddell, K; Wilson, MG |
